NCT04103216View on ClinicalTrials.gov

Treatment of Cryptosporidiosis

NACompletedINTERVENTIONAL
Enrollment

64

Participants

Timeline

Start Date

February 1, 2020

Primary Completion Date

December 31, 2022

Study Completion Date

August 31, 2023

Conditions
Cryptosporidiosis
Interventions
OTHER

Nitazoxanide with Lactobacillus Reuteri DSM 17938

Nitazoxanide with probiotics

OTHER

Nitazoxanide

Nitazoxanide with placebo

Trial Locations (1)

1212

Icddr,B, Dhaka

All Listed Sponsors
collaborator

University of Virginia

OTHER

lead

International Centre for Diarrhoeal Disease Research, Bangladesh

OTHER

NCT04103216 - Treatment of Cryptosporidiosis | Biotech Hunter | Biotech Hunter